Developing a nanosensor platform to detect disease signatures in patient fluids
Official title: Nanosensor Array Platform to Capture Whole Disease Fingerprints
Funded at Sloan-Kettering Inst Can Research · NIH-11092179 · Data updated 2026-11-12
This study is working on a tiny sensor that can help doctors spot different diseases by looking at blood samples, using smart technology to make sure they can tell the difference between healthy and sick patients more accurately.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | June 15, 2023 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $643,764 |
| NIH project number | 5R01EB033651-03 |
| Project ID | NIH-11092179 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with conditions that currently lack specific biomarkers for diagnosis.
✕Less likely to help
Patients with well-established biomarkers or those not undergoing diagnostic testing may not benefit from this research.
What this research studies
This research focuses on creating a nanosensor array that can identify unique disease fingerprints from biofluids like blood serum. By analyzing the interactions of various molecules with these sensors, the project aims to enhance the accuracy of disease diagnosis and biomarker discovery. The approach utilizes machine learning to interpret complex data sets, allowing for better differentiation between healthy and diseased states. This innovative technology seeks to overcome the limitations of current biomarkers, which often lack specificity.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and early diagnoses of diseases, improving patient outcomes.
How similar studies have gone: While the approach of using nanosensors for biomarker discovery is innovative, similar technologies have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Heller, Daniel Alan — Sloan-Kettering Inst Can Research
- Study coordinator: Heller, Daniel Alan
Related research
Other NIH-funded projects on the same topics.
-
Understand how skeletal muscle nuclei specialize and arrange themselves for proper muscle function
A study to uncover how the hundreds of nuclei in skeletal muscle fibers acquire different roles and positions to keep muscles strong and healthy.
-
Genomic profiling and outcomes of cancers in World Trade Center-exposed survivors and responders
This project looks at the genetic makeup and real-world cancer outcomes in people exposed to the World Trade Center disaster to understand how their cancers behave and respond to treatments.
-
Meaning-Centered Psychotherapy for Mexican Patients with Advanced Cancer
A cancer center in Mexico will test a culturally adapted therapy to help Mexican patients with advanced cancer find meaning, peace, and purpose at the end of life.
-
High-specificity genome-scale cell-surface proteomics to find tumor targets
A cancer research project is trying to map all the proteins on the surface of ultra-rare sarcoma cells to find safe, targeted ways to treat them.
-
Priorities for testing and choosing combination therapies in rhabdoid tumors to guide clinical trials
A coordinated, multi-site effort will rigorously test promising drug combinations in rhabdoid tumors to identify the most promising options for future patient trials.
-
ecDNA in Cancer: Understanding and targeting circular DNA that drives tumor growth
A cancer-focused project to understand how extrachromosomal DNA helps tumors grow and resist treatment, and to develop new ways to target these mechanisms.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.